Deals

Qilu Pharmaceutical Drops RMB 400 Million Equity Stake in TYK Medicines – But TY‑9591 Licensing and China Commercialization Deal Stays Alive
HKG: 2410Qilu Pharmaceutical

Qilu Pharmaceutical Drops RMB 400 Million Equity Stake in TYK Medicines – But TY‑9591 Licensing and China Commercialization Deal Stays Alive

TYK Medicines (HKG: 2410) announced that Qilu Pharmaceutical will no longer subscribe for 63,222,744 H shares of the company – terminating the equity leg of their July strategic partnership while…

Medicovestor Completes Seed Funding Round to Advance Next-Generation Antibody and ADC Pipeline – MC004 Naked Antibody Targets FDA IND Filing by Early 2027

Medicovestor Completes Seed Funding Round to Advance Next-Generation Antibody and ADC Pipeline – MC004 Naked Antibody Targets FDA IND Filing by Early 2027

Orbis Medicines Signs Strategic Collaboration and License Deal with Novo Nordisk – Up to $1.4 Billion to Advance Next-Generation Oral Macrocycle Cardiometabolic Therapies

Orbis Medicines Signs Strategic Collaboration and License Deal with Novo Nordisk – Up to $1.4 Billion to Advance Next-Generation Oral Macrocycle Cardiometabolic Therapies

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Sanyou Biopharmaceuticals and Liveriver Bio‑Tech Forge Automation‑Driven Alliance to Accelerate Biologic Development
AILiferiver Bio-Tech

Sanyou Biopharmaceuticals and Liferiver Bio-Tech Forge Automation‑Driven Alliance to Accelerate Biologic Development

TransThera Sciences and Neurocrine Biosciences Ink $881.5 M NLRP3 Collaboration
BiotechHKG: 2617

TransThera Sciences and Neurocrine Biosciences Ink $881.5 M NLRP3 Collaboration

Betta Pharma Secures Exclusive Greater‑China Rights to Gensciences’ Long‑Acting Factor VIII Therapy
Betta PharmaceuticalsBiotech

Betta Pharma Secures Exclusive Greater‑China Rights to Gensciences’ Long‑Acting Factor VIII Therapy

CTTQ Deepens Partnership with Shionogi to Accelerate Naldemedine Launch in China
Boao Lecheng pilot zoneChia Tai Tianqing Pharmaceutical

CTTQ Deepens Partnership with Shionogi to Accelerate Naldemedine Launch in China

Show More